These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13534323)

  • 1. [Relation between prostate hypertrophy and carcinoma of prostate].
    DONTENWILL W; WULF H
    Arch Geschwulstforsch; 1958; 12(1):14-8. PubMed ID: 13534323
    [No Abstract]   [Full Text] [Related]  

  • 2. Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate.
    Stamatiou K; Alevizos A; Natzar M; Mihas C; Mariolis A; Michalodimitrakis E; Sofras F
    Asian J Androl; 2007 Mar; 9(2):229-33. PubMed ID: 16751999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal sex determination of the prostate.
    KUDISH HG; BAUER HM
    J Urol; 1958 May; 79(5):878-81. PubMed ID: 13539979
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum prostatic acid-phosphatase levels in proved cases of carcinoma or benign hypertrophy of the prostate.
    WHITMORE WF; BODANSKY O; SCHWARTZ MK; YING SH; DAY E
    Cancer; 1956; 9(2):228-33. PubMed ID: 13304837
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormonal balance of prostate hypertrophy; its changes caused by adenomectomy].
    FABRE J; FABRE P; BOUISSOU H
    J Urol Medicale Chir; 1957; 63(7-8):497-517. PubMed ID: 13482045
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prostatic hypertrophy and prostate carcinoma].
    Bruni P; Trocino S
    Riforma Med; 1965 Aug; 79(34):939-40. PubMed ID: 4158847
    [No Abstract]   [Full Text] [Related]  

  • 7. The frequency of benign prostate hypertrophy in Calabar.
    Umezurike BI; Ekanem TB; Eluwa MA; Etta KK; Udo-Affah GA; Aligwekwe AU
    Niger Postgrad Med J; 2006 Sep; 13(3):236-9. PubMed ID: 17278305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies of the endocrine dependence of the diffuse prostate hyperplasia and the prostate adenoma].
    CHWALLA R
    Z Urol; 1954; Spec Issue():339-85. PubMed ID: 14360444
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level.
    Punglia RS; D'Amico AV; Catalona WJ; Roehl KA; Kuntz KM
    Cancer; 2006 Apr; 106(7):1507-13. PubMed ID: 16518812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The changes produced by hormone therapy in the pathologic-anatomical picture of hypertrophy and carcinoma of the prostate].
    KANDREBIOTES N
    Hell Iatr; 1960 Jun; 29():613-24. PubMed ID: 13751150
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neoplasms & hyperplasia of Sertoli's cell associated with hypertrophy & carcinoma of the prostate].
    ALTIERI A; SORRENTINO F
    Riforma Med; 1957 May; 71(18):499-505. PubMed ID: 13442485
    [No Abstract]   [Full Text] [Related]  

  • 12. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B; Jaswal TS; Arora B
    Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate.
    Dema A; Tudose N
    Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
    Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
    Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytofunctional picture of the anterior hypophysis in stillbene treatment & after prostatectomy in adenomatous hypertrophy of the prostate].
    CAVALLINI A; FERRANTI L
    Arcisp S Anna Ferrara; 1958; 11(5):953-67. PubMed ID: 13596207
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytogenetic changes and loss of heterozygosity in atypical adenomatous hyperplasia, in carcinoma of the prostate and in non-neoplastic prostate tissue using comparative genomic hybridization and multiplex-PCR.
    Bettendorf O; Schmidt H; Eltze E; Gockel I; Semjonow A; Bürger H; Böcker W; Brandt B
    Int J Oncol; 2005 Jan; 26(1):267-74. PubMed ID: 15586249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein expression in human prostate gland.
    Bataineh ZM; Nusier MK
    Saudi Med J; 2003 Nov; 24(11):1246-9. PubMed ID: 14647563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary research on body fluids in prostate hypertrophy].
    SALVINI L; VIOLA S
    Minerva Med; 1956 May; 47(41):1549-50. PubMed ID: 13348256
    [No Abstract]   [Full Text] [Related]  

  • 19. [Expression of kinase insert domain-containing receptor in prostate adenocarcinoma].
    Bai AS; Zeng H; Li X; Wei Q; Li H; Yang YR
    Zhonghua Nan Ke Xue; 2007 Apr; 13(4):324-6. PubMed ID: 17491265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate.
    Kumar SM
    J Urol; 2005 Feb; 173(2):511-3. PubMed ID: 15643231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.